BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Tissue inhibitor of metalloproteinases 1 (TIMP1)

January 28, 2016 8:00 AM UTC

In vitro and mouse studies suggest inhibiting TIMP1 could help treat glioblastoma multiforme (GBM). In GBM patients, low TIMP1 expression in tumors correlated with overall survival. In a mouse model o...